Immunogenicity Evaluation of a SARS-CoV-2 BA.2 Subunit Vaccine Formulated with CpG 1826 plus alum Dual Adjuvant.
The Sot protein formulated with CpG 1826 plus alum dual adjuvant showed that the excellent cellular and humoral immunogenicity, which provided a scientific basis for the development of BA.2 variant subunit vaccines and references for the adjuvant application of subunit vaccines.
Authors
- Yi Yao (ORCID: https://orcid.org/0000-0003-3110-1720)
- Qiudong Su
- Shengli Bi (ORCID: https://orcid.org/0000-0002-0380-5790)
- Liping Shen
- Yuhan Yan
Institutions
- National Institute for Viral Disease Control and Prevention (CN)
Publication Details
- Journal
- PubMed
- Published
- 2024-12-20
- DOI
- https://doi.org/10.3967/bes2024.129
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00